APO Research
Talk to an analyst

APO RESEARCH · REPORT

Kidney Transplant Rejection Therapeutics

Compare research editions
View pricing & licenses

Selected research

Industry Research

Kidney Transplant Rejection Therapeutics Industry Research Report 2026

22 December 2025123 pages

Choose your research edition.

Industry ResearchKidney Transplant Rejection Therapeutics Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Kidney Transplant Rejection Therapeutics Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Kidney Transplant Rejection Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Kidney Transplant Rejection Therapeutics Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Kidney Transplant Rejection Therapeutics Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Kidney Transplant Rejection Therapeutics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Kidney Transplant Rejection Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Kidney Transplant Rejection Therapeutics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Kidney Transplant Rejection Therapeutics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Kidney Transplant Rejection Therapeutics include Novartis AG, GlaxoSmithKline Plc, Pharming Group N.V., Pharmicell, OSE Immunotherapeutics, Opsona Therapeutics Limited, Noorik Biopharmaceuticals AG, Magnus Life Ltd and Mabtech Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Kidney Transplant Rejection Therapeutics market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Kidney Transplant Rejection Therapeutics Market by Company

Novartis AG

GlaxoSmithKline Plc

Pharming Group N.V.

Pharmicell

OSE Immunotherapeutics

Opsona Therapeutics Limited

Noorik Biopharmaceuticals AG

Magnus Life Ltd

Mabtech Limited

Kyowa Hakko Kirin

Hansa Medical AB

Grifols, S.A.

Digna Biotech, S.L.

CSL Limited

Kidney Transplant Rejection Therapeutics Segment by Type

Cortina

Azathioprine

Cyclophosphamide

Cyclosporin A

Other

Kidney Transplant Rejection Therapeutics Segment by Application

Clinic

Hospital

ASCs

Others

Kidney Transplant Rejection Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney Transplant Rejection Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Kidney Transplant Rejection Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney Transplant Rejection Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Kidney Transplant Rejection Therapeutics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Kidney Transplant Rejection Therapeutics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Kidney Transplant Rejection Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Kidney Transplant Rejection Therapeutics Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Kidney Transplant Rejection Therapeutics Sales (k units) of Manufacturers (2021-2026) Table 7. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Manufacturers (2021-2026) Table 8. Global Kidney Transplant Rejection Therapeutics Revenue of Manufacturers (2021-2026) Table 9. Global Kidney Transplant Rejection Therapeutics Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Kidney Transplant Rejection Therapeutics Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Kidney Transplant Rejection Therapeutics Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Kidney Transplant Rejection Therapeutics, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Kidney Transplant Rejection Therapeutics, Product Type & Application Table 14. Global Kidney Transplant Rejection Therapeutics Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Kidney Transplant Rejection Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Novartis AG Company Information Table 19. Novartis AG Business Overview Table 20. Novartis AG Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Novartis AG Kidney Transplant Rejection Therapeutics Product Portfolio Table 22. Novartis AG Recent Developments Table 23. GlaxoSmithKline Plc Company Information Table 24. GlaxoSmithKline Plc Business Overview Table 25. GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Product Portfolio Table 27. GlaxoSmithKline Plc Recent Developments Table 28. Pharming Group N.V. Company Information Table 29. Pharming Group N.V. Business Overview Table 30. Pharming Group N.V. Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Pharming Group N.V. Kidney Transplant Rejection Therapeutics Product Portfolio Table 32. Pharming Group N.V. Recent Developments Table 33. Pharmicell Company Information Table 34. Pharmicell Business Overview Table 35. Pharmicell Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Pharmicell Kidney Transplant Rejection Therapeutics Product Portfolio Table 37. Pharmicell Recent Developments Table 38. OSE Immunotherapeutics Company Information Table 39. OSE Immunotherapeutics Business Overview Table 40. OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Product Portfolio Table 42. OSE Immunotherapeutics Recent Developments Table 43. Opsona Therapeutics Limited Company Information Table 44. Opsona Therapeutics Limited Business Overview Table 45. Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Product Portfolio Table 47. Opsona Therapeutics Limited Recent Developments Table 48. Noorik Biopharmaceuticals AG Company Information Table 49. Noorik Biopharmaceuticals AG Business Overview Table 50. Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Product Portfolio Table 52. Noorik Biopharmaceuticals AG Recent Developments Table 53. Magnus Life Ltd Company Information Table 54. Magnus Life Ltd Business Overview Table 55. Magnus Life Ltd Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Magnus Life Ltd Kidney Transplant Rejection Therapeutics Product Portfolio Table 57. Magnus Life Ltd Recent Developments Table 58. Mabtech Limited Company Information Table 59. Mabtech Limited Business Overview Table 60. Mabtech Limited Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Mabtech Limited Kidney Transplant Rejection Therapeutics Product Portfolio Table 62. Mabtech Limited Recent Developments Table 63. Kyowa Hakko Kirin Company Information Table 64. Kyowa Hakko Kirin Business Overview Table 65. Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Product Portfolio Table 67. Kyowa Hakko Kirin Recent Developments Table 68. Hansa Medical AB Company Information Table 69. Hansa Medical AB Business Overview Table 70. Hansa Medical AB Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Hansa Medical AB Kidney Transplant Rejection Therapeutics Product Portfolio Table 72. Hansa Medical AB Recent Developments Table 73. Grifols, S.A. Company Information Table 74. Grifols, S.A. Business Overview Table 75. Grifols, S.A. Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Grifols, S.A. Kidney Transplant Rejection Therapeutics Product Portfolio Table 77. Grifols, S.A. Recent Developments Table 78. Digna Biotech, S.L. Company Information Table 79. Digna Biotech, S.L. Business Overview Table 80. Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Product Portfolio Table 82. Digna Biotech, S.L. Recent Developments Table 83. CSL Limited Company Information Table 84. CSL Limited Business Overview Table 85. CSL Limited Kidney Transplant Rejection Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. CSL Limited Kidney Transplant Rejection Therapeutics Product Portfolio Table 87. CSL Limited Recent Developments Table 88. Global Kidney Transplant Rejection Therapeutics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Kidney Transplant Rejection Therapeutics Sales by Region (2021-2026) & (k units) Table 90. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Region (2021-2026) Table 91. Global Kidney Transplant Rejection Therapeutics Sales by Region (2027-2032) & (k units) Table 92. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Region (2027-2032) Table 93. Global Kidney Transplant Rejection Therapeutics Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Region (2021-2026) Table 95. Global Kidney Transplant Rejection Therapeutics Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Region (2027-2032) Table 97. North America Kidney Transplant Rejection Therapeutics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (k units) Table 99. North America Kidney Transplant Rejection Therapeutics Sales by Country (2027-2032) & (k units) Table 100. North America Kidney Transplant Rejection Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Kidney Transplant Rejection Therapeutics Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Kidney Transplant Rejection Therapeutics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (k units) Table 104. Europe Kidney Transplant Rejection Therapeutics Sales by Country (2027-2032) & (k units) Table 105. Europe Kidney Transplant Rejection Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Kidney Transplant Rejection Therapeutics Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Kidney Transplant Rejection Therapeutics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (k units) Table 109. Asia Pacific Kidney Transplant Rejection Therapeutics Sales by Country (2027-2032) & (k units) Table 110. Asia Pacific Kidney Transplant Rejection Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Kidney Transplant Rejection Therapeutics Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Kidney Transplant Rejection Therapeutics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (k units) Table 114. South America Kidney Transplant Rejection Therapeutics Sales by Country (2027-2032) & (k units) Table 115. South America Kidney Transplant Rejection Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Kidney Transplant Rejection Therapeutics Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (k units) Table 119. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Country (2027-2032) & (k units) Table 120. Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Kidney Transplant Rejection Therapeutics Sales by Type (2021-2026) & (k units) Table 123. Global Kidney Transplant Rejection Therapeutics Sales by Type (2027-2032) & (k units) Table 124. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2021-2026) Table 125. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2027-2032) Table 126. Global Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Kidney Transplant Rejection Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type (2021-2026) Table 129. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type (2027-2032) Table 130. Global Kidney Transplant Rejection Therapeutics Price by Type (2021-2026) & (US$/unit) Table 131. Global Kidney Transplant Rejection Therapeutics Price by Type (2027-2032) & (US$/unit) Table 132. Global Kidney Transplant Rejection Therapeutics Sales by Application (2021-2026) & (k units) Table 133. Global Kidney Transplant Rejection Therapeutics Sales by Application (2027-2032) & (k units) Table 134. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2021-2026) Table 135. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2027-2032) Table 136. Global Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Kidney Transplant Rejection Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application (2021-2026) Table 139. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application (2027-2032) Table 140. Global Kidney Transplant Rejection Therapeutics Price by Application (2021-2026) & (US$/unit) Table 141. Global Kidney Transplant Rejection Therapeutics Price by Application (2027-2032) & (US$/unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Kidney Transplant Rejection Therapeutics Distributors List Table 145. Kidney Transplant Rejection Therapeutics Customers List Table 146. Kidney Transplant Rejection Therapeutics Industry Trends Table 147. Kidney Transplant Rejection Therapeutics Industry Drivers Table 148. Kidney Transplant Rejection Therapeutics Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Kidney Transplant Rejection Therapeutics Product Image Figure 5. Global Kidney Transplant Rejection Therapeutics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Kidney Transplant Rejection Therapeutics Market Size (2021-2032) & (US$ Million) Figure 7. Global Kidney Transplant Rejection Therapeutics Sales (2021-2032) & (k units) Figure 8. Global Kidney Transplant Rejection Therapeutics Average Price (US$/unit) & (2021-2032) Figure 9. Cortina Product Image Figure 10. Azathioprine Product Image Figure 11. Cyclophosphamide Product Image Figure 12. Cyclosporin A Product Image Figure 13. Other Product Image Figure 14. Clinic Product Image Figure 15. Hospital Product Image Figure 16. ASCs Product Image Figure 17. Others Product Image Figure 18. Global Kidney Transplant Rejection Therapeutics Revenue Share by Manufacturers in 2025 Figure 19. Global Manufacturers of Kidney Transplant Rejection Therapeutics, Manufacturing Sites & Headquarters Figure 20. Global Top 5 and 10 Kidney Transplant Rejection Therapeutics Players Market Share by Revenue in 2025 Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Kidney Transplant Rejection Therapeutics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 23. Global Kidney Transplant Rejection Therapeutics Sales by Region in 2025 Figure 24. Global Kidney Transplant Rejection Therapeutics Revenue by Region in 2025 Figure 25. North America Kidney Transplant Rejection Therapeutics Market Size by Country in 2025 Figure 26. North America Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2021-2032) Figure 27. North America Kidney Transplant Rejection Therapeutics Revenue Market Share by Country (2021-2032) Figure 28. United States Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Canada Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Mexico Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Kidney Transplant Rejection Therapeutics Market Size by Country in 2025 Figure 32. Europe Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2021-2032) Figure 33. Europe Kidney Transplant Rejection Therapeutics Revenue Market Share by Country (2021-2032) Figure 34. Germany Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Russia Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Spain Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Netherlands Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Switzerland Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Sweden Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Poland Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Asia Pacific Kidney Transplant Rejection Therapeutics Market Size by Country in 2025 Figure 45. Asia Pacific Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2021-2032) Figure 46. Asia Pacific Kidney Transplant Rejection Therapeutics Revenue Market Share by Country (2021-2032) Figure 47. China Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Japan Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. South Korea Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. India Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Australia Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Taiwan Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. South America Kidney Transplant Rejection Therapeutics Market Size by Country in 2025 Figure 56. South America Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2021-2032) Figure 57. South America Kidney Transplant Rejection Therapeutics Revenue Market Share by Country (2021-2032) Figure 58. Brazil Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Argentina Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Chile Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Colombia Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Middle East and Africa Kidney Transplant Rejection Therapeutics Market Size by Country in 2025 Figure 63. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2021-2032) Figure 64. Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue Market Share by Country (2021-2032) Figure 65. Egypt Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. South Africa Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Israel Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Türkiye Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. GCC Countries Kidney Transplant Rejection Therapeutics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2021-2032) Figure 71. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type (2021-2032) Figure 72. Global Kidney Transplant Rejection Therapeutics Price (US$/unit) by Type (2021-2032) Figure 73. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2021-2032) Figure 74. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application (2021-2032) Figure 75. Global Kidney Transplant Rejection Therapeutics Price (US$/unit) by Application (2021-2032) Figure 76. Kidney Transplant Rejection Therapeutics Value Chain Figure 77. Kidney Transplant Rejection Therapeutics Production Mode & Process Figure 78. Direct Comparison with Distribution Share Figure 79. Distributors Profiles Figure 80. Kidney Transplant Rejection Therapeutics Industry Opportunities and Challenges

Scope & coverage.

Types
  • Cortina
  • Azathioprine
  • Cyclophosphamide
  • Cyclosporin A
  • Other
Applications
  • Clinic
  • Hospital
  • ASCs
  • Others
Companies covered
  • Novartis AG
  • GlaxoSmithKline Plc
  • Pharming Group N.V.
  • Pharmicell
  • OSE Immunotherapeutics
  • Opsona Therapeutics Limited
  • Noorik Biopharmaceuticals AG
  • Magnus Life Ltd
  • Mabtech Limited
  • Kyowa Hakko Kirin
  • Hansa Medical AB
  • Grifols, S.A.
  • Digna Biotech, S.L.
  • CSL Limited

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Kidney Transplant Rejection Therapeutics Market Size (2021-2032)
  4. 2.2.2 Global Kidney Transplant Rejection Therapeutics Sales (2021-2032)
  5. 2.2.3 Global Kidney Transplant Rejection Therapeutics Market Average Price (2021-2032)
  6. 2.3 Kidney Transplant Rejection Therapeutics by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Cortina
  9. 2.3.3 Azathioprine
  10. 2.3.4 Cyclophosphamide
  11. 2.3.5 Cyclosporin A
  12. 2.3.6 Other
  13. 2.4 Kidney Transplant Rejection Therapeutics by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Clinic
  16. 2.4.3 Hospital
  17. 2.4.4 ASCs
  18. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Kidney Transplant Rejection Therapeutics Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Kidney Transplant Rejection Therapeutics Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Kidney Transplant Rejection Therapeutics Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Kidney Transplant Rejection Therapeutics Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Kidney Transplant Rejection Therapeutics Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Kidney Transplant Rejection Therapeutics, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Kidney Transplant Rejection Therapeutics, Product Type & Application
  8. 3.8 Global Manufacturers of Kidney Transplant Rejection Therapeutics, Established Date
  9. 3.9 Global Kidney Transplant Rejection Therapeutics Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Novartis AG
  2. 4.1.1 Novartis AG Company Information
  3. 4.1.2 Novartis AG Business Overview
  4. 4.1.3 Novartis AG Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Novartis AG Kidney Transplant Rejection Therapeutics Product Portfolio
  6. 4.1.5 Novartis AG Recent Developments
  7. 4.2 GlaxoSmithKline Plc
  8. 4.2.1 GlaxoSmithKline Plc Company Information
  9. 4.2.2 GlaxoSmithKline Plc Business Overview
  10. 4.2.3 GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Product Portfolio
  12. 4.2.5 GlaxoSmithKline Plc Recent Developments
  13. 4.3 Pharming Group N.V.
  14. 4.3.1 Pharming Group N.V. Company Information
  15. 4.3.2 Pharming Group N.V. Business Overview
  16. 4.3.3 Pharming Group N.V. Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Pharming Group N.V. Kidney Transplant Rejection Therapeutics Product Portfolio
  18. 4.3.5 Pharming Group N.V. Recent Developments
  19. 4.4 Pharmicell
  20. 4.4.1 Pharmicell Company Information
  21. 4.4.2 Pharmicell Business Overview
  22. 4.4.3 Pharmicell Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Pharmicell Kidney Transplant Rejection Therapeutics Product Portfolio
  24. 4.4.5 Pharmicell Recent Developments
  25. 4.5 OSE Immunotherapeutics
  26. 4.5.1 OSE Immunotherapeutics Company Information
  27. 4.5.2 OSE Immunotherapeutics Business Overview
  28. 4.5.3 OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Product Portfolio
  30. 4.5.5 OSE Immunotherapeutics Recent Developments
  31. 4.6 Opsona Therapeutics Limited
  32. 4.6.1 Opsona Therapeutics Limited Company Information
  33. 4.6.2 Opsona Therapeutics Limited Business Overview
  34. 4.6.3 Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Product Portfolio
  36. 4.6.5 Opsona Therapeutics Limited Recent Developments
  37. 4.7 Noorik Biopharmaceuticals AG
  38. 4.7.1 Noorik Biopharmaceuticals AG Company Information
  39. 4.7.2 Noorik Biopharmaceuticals AG Business Overview
  40. 4.7.3 Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Product Portfolio
  42. 4.7.5 Noorik Biopharmaceuticals AG Recent Developments
  43. 4.8 Magnus Life Ltd
  44. 4.8.1 Magnus Life Ltd Company Information
  45. 4.8.2 Magnus Life Ltd Business Overview
  46. 4.8.3 Magnus Life Ltd Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Magnus Life Ltd Kidney Transplant Rejection Therapeutics Product Portfolio
  48. 4.8.5 Magnus Life Ltd Recent Developments
  49. 4.9 Mabtech Limited
  50. 4.9.1 Mabtech Limited Company Information
  51. 4.9.2 Mabtech Limited Business Overview
  52. 4.9.3 Mabtech Limited Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Mabtech Limited Kidney Transplant Rejection Therapeutics Product Portfolio
  54. 4.9.5 Mabtech Limited Recent Developments
  55. 4.10 Kyowa Hakko Kirin
  56. 4.10.1 Kyowa Hakko Kirin Company Information
  57. 4.10.2 Kyowa Hakko Kirin Business Overview
  58. 4.10.3 Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Product Portfolio
  60. 4.10.5 Kyowa Hakko Kirin Recent Developments
  61. 4.11 Hansa Medical AB
  62. 4.11.1 Hansa Medical AB Company Information
  63. 4.11.2 Hansa Medical AB Business Overview
  64. 4.11.3 Hansa Medical AB Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Hansa Medical AB Kidney Transplant Rejection Therapeutics Product Portfolio
  66. 4.11.5 Hansa Medical AB Recent Developments
  67. 4.12 Grifols, S.A.
  68. 4.12.1 Grifols, S.A. Company Information
  69. 4.12.2 Grifols, S.A. Business Overview
  70. 4.12.3 Grifols, S.A. Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Grifols, S.A. Kidney Transplant Rejection Therapeutics Product Portfolio
  72. 4.12.5 Grifols, S.A. Recent Developments
  73. 4.13 Digna Biotech, S.L.
  74. 4.13.1 Digna Biotech, S.L. Company Information
  75. 4.13.2 Digna Biotech, S.L. Business Overview
  76. 4.13.3 Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Product Portfolio
  78. 4.13.5 Digna Biotech, S.L. Recent Developments
  79. 4.14 CSL Limited
  80. 4.14.1 CSL Limited Company Information
  81. 4.14.2 CSL Limited Business Overview
  82. 4.14.3 CSL Limited Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 CSL Limited Kidney Transplant Rejection Therapeutics Product Portfolio
  84. 4.14.5 CSL Limited Recent Developments
5 Global Kidney Transplant Rejection Therapeutics Market Scenario by Region
  1. 5.1 Global Kidney Transplant Rejection Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Kidney Transplant Rejection Therapeutics Sales by Region: 2021-2032
  3. 5.2.1 Global Kidney Transplant Rejection Therapeutics Sales by Region: 2021-2026
  4. 5.2.2 Global Kidney Transplant Rejection Therapeutics Sales by Region: 2027-2032
  5. 5.3 Global Kidney Transplant Rejection Therapeutics Revenue by Region: 2021-2032
  6. 5.3.1 Global Kidney Transplant Rejection Therapeutics Revenue by Region: 2021-2026
  7. 5.3.2 Global Kidney Transplant Rejection Therapeutics Revenue by Region: 2027-2032
  8. 5.4 North America Kidney Transplant Rejection Therapeutics Market Facts & Figures by Country
  9. 5.4.1 North America Kidney Transplant Rejection Therapeutics Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Kidney Transplant Rejection Therapeutics Sales by Country (2021-2032)
  11. 5.4.3 North America Kidney Transplant Rejection Therapeutics Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Kidney Transplant Rejection Therapeutics Market Facts & Figures by Country
  16. 5.5.1 Europe Kidney Transplant Rejection Therapeutics Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Kidney Transplant Rejection Therapeutics Sales by Country (2021-2032)
  18. 5.5.3 Europe Kidney Transplant Rejection Therapeutics Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Kidney Transplant Rejection Therapeutics Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Kidney Transplant Rejection Therapeutics Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Kidney Transplant Rejection Therapeutics Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Kidney Transplant Rejection Therapeutics Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Kidney Transplant Rejection Therapeutics Market Facts & Figures by Country
  41. 5.7.1 South America Kidney Transplant Rejection Therapeutics Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Kidney Transplant Rejection Therapeutics Sales by Country (2021-2032)
  43. 5.7.3 South America Kidney Transplant Rejection Therapeutics Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Kidney Transplant Rejection Therapeutics Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Kidney Transplant Rejection Therapeutics Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Kidney Transplant Rejection Therapeutics Sales by Type (2021-2032)
  2. 6.1.1 Global Kidney Transplant Rejection Therapeutics Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2021-2032)
  4. 6.2 Global Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2032)
  5. 6.2.1 Global Kidney Transplant Rejection Therapeutics Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Kidney Transplant Rejection Therapeutics Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Kidney Transplant Rejection Therapeutics Sales by Application (2021-2032)
  2. 7.1.1 Global Kidney Transplant Rejection Therapeutics Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2021-2032)
  4. 7.2 Global Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2032)
  5. 7.2.1 Global Kidney Transplant Rejection Therapeutics Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Kidney Transplant Rejection Therapeutics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Kidney Transplant Rejection Therapeutics Value Chain Analysis
  2. 8.1.1 Kidney Transplant Rejection Therapeutics Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Kidney Transplant Rejection Therapeutics Production Mode & Process
  5. 8.2 Kidney Transplant Rejection Therapeutics Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Kidney Transplant Rejection Therapeutics Distributors
  8. 8.2.3 Kidney Transplant Rejection Therapeutics Customers
9 Global Kidney Transplant Rejection Therapeutics Analyzing Market Dynamics
  1. 9.1 Kidney Transplant Rejection Therapeutics Industry Trends
  2. 9.2 Kidney Transplant Rejection Therapeutics Industry Drivers
  3. 9.3 Kidney Transplant Rejection Therapeutics Industry Opportunities and Challenges
  4. 9.4 Kidney Transplant Rejection Therapeutics Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst